g protein Archive — Page 1 of 1

From left, Sheila Collins, PhD, Ryan Ceddia, PhD, and Heidi Hamm, PhD, and their colleagues have identified a potential new approach to reducing the global impact of obesity and diabetes. (photo by Erin O. Smith)
September 6, 2023

Releasing a brake that drives obesity and diabetes

Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes.

By Bill Snyder
Laboratory pipette dispensing an amber liquid into a clear multiwell test plate, with a blurred chemical structure in the background.
March 28, 2019

Cancer’s SOS

Stephen Fesik and colleagues are advancing cancer drug discovery with the characterization of small molecules that modulate RAS, an important target for anti-cancer therapies.

By Sanjay Mishra
(iStockphoto)
December 2, 2013

VU researchers report G protein advancement that could lead to more effective drugs

Thanks in part to a computer program named “Rosetta,” Vanderbilt University researchers are closer to understanding how the ubiquitous G protein is activated – a discovery that could lead to the design of more specific and effective drugs.

By Bill Snyder
Smiling woman with short light-brown hair and a reddish-brown patterned top, photographed indoors at a desk. The attachment caption identifies her as Heidi Hamm, Ph.D.
October 25, 2012

Hamm’s research honored by Dutch pharmacology society

Heidi Hamm, Ph.D., chair of the Department of Pharmacology, has won the 2012 Ariens Award from the Dutch Pharmacological Society.

By Bill Snyder
Scientific illustration of a magenta G protein-coupled receptor embedded in a gray cell membrane, attached to blue, green, and gold G-protein subunits. Green and red molecular models with arrows indicate exchange of GTP for GDP.
October 18, 2012

Nobel in Chemistry reveals VU ties that bind

Several Vanderbilt researchers have collaborated with this year’s Nobel Chemistry winners.

By Bill Snyder